TrialNet Locations

With more than 200 locations offering Pathway to Prevention screening and the option to get a test kit in the mail to take to a local lab, it’s easy to participate. These Centers coordinate all the TrialNet sites in their geographical region.

Find a Location

from

United States

Barbara Davis Center

University of Colorado Anschutz Medical Campus

Aurora, CO

The Barbara Davis Center is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Peter Gottlieb, MD, the TrialNet team at the Barbara Davis Center is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Baylor College of Medicine

Texas Children's Hospital

Houston, TX

Baylor College of Medicine/Texas Children’s Hospital (Baylor/TCH) is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Dr. Maria J. Redondo, the TrialNet team at Baylor/TCH is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Benaroya Research Institute

Diabetes Clinical Research Program

Seattle, WA

Benaroya Research Institute (BRI) is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Carla Greenbaum, MD, the TrialNet team at BRI is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Children's Mercy Hospital

Kansas City, MO

Children's Mercy Hospital is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Wayne Moore, MD, PhD the TrialNet team at Children's Mercy is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Columbia University

Naomi Berrie Diabetes Center

New York, NY

Columbia University is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Robin Goland, MD, the TrialNet team at Columbia University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Emory Children's Center

Emory University

Atlanta, GA

Emory Children’s Center is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Andrew Muir, MD, the TrialNet team at Emory is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Riley Hospital for Children

Riley Hospital for Children

Indiana University

Indianapolis, IN

Riley Hospital for Children is one of twenty-five Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Principal Investigator, Linda DiMeglio, MD, the TrialNet team at the Riley's is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Stanford University

Division of Endocrinology and Diabetes

Stanford, CA

Stanford University is one of twenty-five type 1 diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Darrell Wilson, MD, the TrialNet team at Stanford University is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

University of California, San Francisco

San Francisco, CA

University of California, San Francisco (UCSF) is one of twenty-five Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Stephen Gitelman, MD, the TrialNet team at UCSF is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

University of Chicago

Kovler Diabetes Center

Chicago, IL

The University of Chicago is one of twenty-five Type 1 Diabetes TrialNet International Clinical Centers at the forefront of type 1 diabetes research. Led by Principal Investigator, Lou Philipson, MD, the TrialNet team at the University of Chicago is dedicated to preventing type 1 diabetes and stopping disease progression by preserving insulin production before and after diagnosis.

Pages